Clinical Pathology Laboratories Using Back-Office Technologies to Improve Productivity and Increase Cash Collections

Strategy is to use automation and new informatics solutions to improve productivity of medical lab’s billing and collection departments

Relentless pressure to cut costs is pushing the nation’s clinical laboratories to finally look at back-office functions as a source of important cost reductions. That is a new trend in the medical laboratory testing industry.

“No one should be surprised by this development,” stated Lâle White, CEO of XIFIN, Inc., of San Diego, California. “When it came to cutting costs, for the better part of two decades, most clinical laboratories put priority emphasis on the pre-analytical and analytical stages of their lab operations. This was a good strategy and has produced substantial gains in quality and productivity, even as labs were able to better manage costs. (more…)

New Genetic Laboratory Tests Face Complicated Hurdles to Win Reimbursement

Health insurers not eager to establish coverage for new molecular diagnostic assays

Navigating the pathway to successful commercialization of new genetic tests and molecular diagnostic assays has proven tricky. While scientists work quickly to bring new and better clinical laboratory testing tools to the market, health insurers work at a much slower pace to issue coverage guidelines and establish reimbursement for these new diagnostics tests.

“Successfully moving a genetic test from the research bench to the clinical laboratory takes much more than an understanding of the science,” stated Rina Wolf, Vice President of Commercialization Strategies for Consulting and Industry Affairs, XIFIN Inc., of San Diego, California. “Competition for coverage and reimbursement by health insurers is fierce. Often, the molecular diagnostic tests that win the best coverage decisions by payers are those proprietary tests backed by companies and laboratories with the most effective business plans.”